Sana Biotechnology (SANA)
(Delayed Data from NSDQ)
$1.65 USD
+0.05 (3.13%)
Updated Dec 20, 2024 04:00 PM ET
After-Market: $1.67 +0.02 (1.21%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 3/6/25 |
---|---|
Current Quarter | -0.25 |
EPS Last Quarter | -0.25 |
Last EPS Surprise | 3.85% |
ABR | 1.75 |
Earnings ESP
|
-25.25% |
---|---|
Current Year | -1.23 |
Next Year | -0.84 |
EPS (TTM) | -1.24 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.25 | -0.19 | -1.23 | -0.84 |
# of Estimates | 4 | 1 | 4 | 5 |
Most Recent Consensus | -0.21 | NA | -1.17 | -0.83 |
High Estimate | -0.21 | -0.19 | -1.17 | -0.68 |
Low Estimate | -0.31 | -0.19 | -1.30 | -1.08 |
Year ago EPS | -0.35 | -0.32 | -1.63 | -1.23 |
Year over Year Growth Est. | 28.57% | 40.63% | 24.54% | 31.50% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 0 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.25 | -0.19 | -1.23 | -0.84 |
7 Days Ago | -0.25 | -0.19 | -1.23 | -0.84 |
30 Days Ago | -0.23 | -0.19 | -1.23 | -0.85 |
60 Days Ago | -0.25 | -0.25 | -1.18 | -1.01 |
90 Days Ago | -0.25 | -0.25 | -1.18 | -1.08 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.31 | -0.19 | -1.23 | -0.80 |
Zacks Consensus Estimate | -0.25 | -0.19 | -1.23 | -0.84 |
Earnings ESP | -25.25% | 0.00% | 0.00% | 4.76% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.25 | -0.32 | -0.32 | -0.35 | NA |
Estimate | -0.26 | -0.27 | -0.30 | -0.37 | NA |
Difference | 0.01 | -0.05 | -0.02 | 0.02 | -0.01 |
Surprise | 3.85% | -18.52% | -6.67% | 5.41% | -3.98% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more